DURECT Corporation (DRRX) Plunges 6.04% on March 26

DURECT Corporation (DRRX) Plunges 6.04% on March 26

DURECT Corporation (DRRX) had a rough trading day for Tuesday March 26 as shares tumbled 6.04%, or a loss of $-0.0412 per share, to close at $0.64. After opening the day at $0.71, shares of DURECT Corporation traded as high as $0.71 and as low as $0.62. Volume was 421,181 shares over 994 trades, against an average daily volume of n/a shares and a total float of 162.06 million.

As a result of the decline, DURECT Corporation now has a market cap of $103.88 million. In the last year, shares of DURECT Corporation have traded between a range of $2.55 and $0.46, and its 50-day SMA is currently $n/a and 200-day SMA is $n/a.

Durect Corp is a biopharmaceutical company. It is engaged in the research, development and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and drug delivery programs. The company’s pipeline products consist of DUR-928, RBP-7000, Remoxy, POSIMIR, and others.

DURECT Corporation is based out of Cupertino, CA and has some 88 employees. Its CEO is James E. Brown.

Share:
Scroll Up
error: Content is protected !!